Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-24

FDA Approved: METOPROLOL — Supplemental Application (Baxter Healthcare Corporation)

View source ↗

Summary

The FDA approved Baxter Healthcare Corporation's supplemental application for Metoprolol Tartrate under ANDA 078950. This approval updates an existing generic m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METOPROLOL TARTRATE (METOPROLOL TARTRATE)

Snippet

SUPPL AP for METOPROLOL (METOPROLOL TARTRATE)